| Bridgeport Pharmacy | |
| 978 East Main Street, Bridgeport, Connecticut 06608 | |
| (203) 367-9000 |
| Name | Bridgeport Pharmacy |
|---|---|
| Organization Name | Bridgeport Pharmacy, Llc |
| Location | 978 East Main Street, Bridgeport, Connecticut 06608 |
| Type | Pharmacy |
| Phone | (203) 367-9000 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Consumption of resistant starch leads to positive changes in the bowel and could protect against genetic damage implicated in bowel cancer.
ARIAD Pharmaceuticals, Inc. today announced long-term results of the Phase 1 study of its investigational pan-BCR-ABL inhibitor, ponatinib, in heavily pretreated patients with resistant and refractory chronic myeloid leukemia (CML) and Philadelphia-positive acute lymphoblastic leukemia.
Banyan Biomarkers, Inc., the leader in developing in vitro diagnostic products to detect traumatic brain injury (TBI), announced today that they have been awarded a $26.3 Million Contract for the development of a diagnostic test for TBI.
A team led by researchers at the RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan has developed a way to engineer glycan complexes-clusters of sugar chains attached to proteins or lipids-in a way that allows the molecules to be transported preferentially to specific organs of the body, depending on the sugar chains contained in the cluster.
Adamis Pharmaceuticals Corporation announced on July 23 that its wholly owned subsidiary, Adamis Labs launched and shipped the first orders of the company's Epinephrine Injection, USP, 1:1000 (0.3mg prefilled single dose syringe) ("PFS"). Today, Adamis Labs reports that at least two major data base reference companies (Medi-Span® and First DataBank) placed the Company's PFS in their generic category.
› Verified 8 days ago
| NPI Number | 1588821789 |
| Organization Name | BRIDGEPORT PHARMACY LLC |
| Doing Business As | BRIDGEPORT PHARMACY |
| Type | Pharmacy |
| Address | 978 E Main St, Bridgeport, CT 06608 |
| Phone Number | 203-367-9000 |
News Archive
Consumption of resistant starch leads to positive changes in the bowel and could protect against genetic damage implicated in bowel cancer.
ARIAD Pharmaceuticals, Inc. today announced long-term results of the Phase 1 study of its investigational pan-BCR-ABL inhibitor, ponatinib, in heavily pretreated patients with resistant and refractory chronic myeloid leukemia (CML) and Philadelphia-positive acute lymphoblastic leukemia.
Banyan Biomarkers, Inc., the leader in developing in vitro diagnostic products to detect traumatic brain injury (TBI), announced today that they have been awarded a $26.3 Million Contract for the development of a diagnostic test for TBI.
A team led by researchers at the RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan has developed a way to engineer glycan complexes-clusters of sugar chains attached to proteins or lipids-in a way that allows the molecules to be transported preferentially to specific organs of the body, depending on the sugar chains contained in the cluster.
Adamis Pharmaceuticals Corporation announced on July 23 that its wholly owned subsidiary, Adamis Labs launched and shipped the first orders of the company's Epinephrine Injection, USP, 1:1000 (0.3mg prefilled single dose syringe) ("PFS"). Today, Adamis Labs reports that at least two major data base reference companies (Medi-Span® and First DataBank) placed the Company's PFS in their generic category.
› Verified 8 days ago
| NPI Number | 1962127787 |
| Organization Name | BRIDGEPORT PHARMACY LLC |
| Type | Long Term Care Pharmacy |
| Address | 978 E Main St, Bridgeport, CT 06608 |
| Phone Number | 203-367-9000 |
News Archive
Consumption of resistant starch leads to positive changes in the bowel and could protect against genetic damage implicated in bowel cancer.
ARIAD Pharmaceuticals, Inc. today announced long-term results of the Phase 1 study of its investigational pan-BCR-ABL inhibitor, ponatinib, in heavily pretreated patients with resistant and refractory chronic myeloid leukemia (CML) and Philadelphia-positive acute lymphoblastic leukemia.
Banyan Biomarkers, Inc., the leader in developing in vitro diagnostic products to detect traumatic brain injury (TBI), announced today that they have been awarded a $26.3 Million Contract for the development of a diagnostic test for TBI.
A team led by researchers at the RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan has developed a way to engineer glycan complexes-clusters of sugar chains attached to proteins or lipids-in a way that allows the molecules to be transported preferentially to specific organs of the body, depending on the sugar chains contained in the cluster.
Adamis Pharmaceuticals Corporation announced on July 23 that its wholly owned subsidiary, Adamis Labs launched and shipped the first orders of the company's Epinephrine Injection, USP, 1:1000 (0.3mg prefilled single dose syringe) ("PFS"). Today, Adamis Labs reports that at least two major data base reference companies (Medi-Span® and First DataBank) placed the Company's PFS in their generic category.
› Verified 8 days ago
News Archive
Consumption of resistant starch leads to positive changes in the bowel and could protect against genetic damage implicated in bowel cancer.
ARIAD Pharmaceuticals, Inc. today announced long-term results of the Phase 1 study of its investigational pan-BCR-ABL inhibitor, ponatinib, in heavily pretreated patients with resistant and refractory chronic myeloid leukemia (CML) and Philadelphia-positive acute lymphoblastic leukemia.
Banyan Biomarkers, Inc., the leader in developing in vitro diagnostic products to detect traumatic brain injury (TBI), announced today that they have been awarded a $26.3 Million Contract for the development of a diagnostic test for TBI.
A team led by researchers at the RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan has developed a way to engineer glycan complexes-clusters of sugar chains attached to proteins or lipids-in a way that allows the molecules to be transported preferentially to specific organs of the body, depending on the sugar chains contained in the cluster.
Adamis Pharmaceuticals Corporation announced on July 23 that its wholly owned subsidiary, Adamis Labs launched and shipped the first orders of the company's Epinephrine Injection, USP, 1:1000 (0.3mg prefilled single dose syringe) ("PFS"). Today, Adamis Labs reports that at least two major data base reference companies (Medi-Span® and First DataBank) placed the Company's PFS in their generic category.
› Verified 8 days ago
Bridgeport Community Pharmacy, Llc. Type: Pharmacy Location: 192 Fairfield Ave, Bridgeport, Connecticut 06604 Phone: (203) 330-9191 | |
Bridgeport Pharmacy Type: Pharmacy Location: 978 East Main Street, Bridgeport, Connecticut 06608 Phone: (203) 367-9000 | |
Cvs Pharmaacy #02143 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3710 Main St, Bridgeport, Connecticut 06606 Phone: (203) 371-1280 | |
Cvs Pharmacy #01139 Type: Medicare Supplier Location: 2610 E Main St, Bridgeport, Connecticut 06610 Phone: (203) 368-0944 | |
Cvs Pharmacy #01153 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1875 Boston Ave, Bridgeport, Connecticut 06610 Phone: (203) 330-8278 |